Body | Page 194 of 274 | SpiritIndia.com

Parkinson’s Disease :: Patients face tough treatment ‘Balancing Act’

Last week, in one of TV ad Actor Michael J. Fox appeared with his disturbingly uncontrolled movements. And, his opponents in the stem-cell debate accused him of either acting or purposefully not taking his medications, in an effort to gain sympathy, quoted by news agencies worldwide. Nothing could be further from the truth, according to Parkinson’s experts. In fact, Fox’s disordered movement — a condition called dyskinesia — was mainly due to his taking medication to help control his Parkinson’s, they said.

Arthritis :: Botox can treat Knee Pain

Mayo Clinic seeks adults who are age 40 or older and have knee pain that has not responded to medicines, exercise or physical therapy for a research study. The purpose of this research study is to find out what effects (good and bad) the botulinum toxin (Botox) has on patients with knee arthritis. Eligible participants will have been diagnosed with knee arthritis that can be confirmed by x-ray.

Macular Degeneration :: Photoswitches could restore sight to blind retinas

A research center newly created by the University of California, Berkeley, and Lawrence Berkeley National Laboratory (LBNL) aims to put light-sensitive switches in the body’s cells that can be flipped on and off as easily as a remote control operates a TV. Optical switches like these could trigger a chemical reaction, initiate a muscle contraction, activate a drug or stimulate a nerve cell – all at the flash of a light.

Hepatitis :: Glaxo eltrombopag improved platelet count in hepatitis C patients with thrombocytopenia

GlaxoSmithKline plc [NYSE:GSK, LSE:GSK] announced results from a global Phase II study of eltrombopag, an investigational non-peptide oral platelet growth factor. In this study of 74 hepatitis C patients with thrombocytopenia, (a condition where the blood has low platelet levels) more than 95% (p< 0.001) of patients treated with the highest dose of eltrombopag (75mg) had increased platelet counts. In addition, 71% - 91% of patients in all treatment groups were able to initiate antiviral therapy with pegylated interferon-α (IFN) and ribavirin, and 65% were able to be maintained on therapy.1 Full results from this Phase II study are being presented today at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, Massachusetts.

Back Pain :: Physical Therapy for the Lower Back – How to Prevent and Treat Lower Back Pain

Lower back pain is one of the most common causes of job-related disability and why some people miss work. It is also the second most common neurological ailment in the United States, second only to headache. In fact, approximately 80% of adults in Western countries have, at some point, experienced lower back pain.

Baby Care :: Defective serotonin pathways in the brainstem may increase infants’ vulnerability – SIDS

New autopsy data provide the strongest evidence yet that sudden infant death syndrome (SIDS) is not a “mystery” disease but has a concrete biological basis. In the November 1 issue of JAMA, researchers at Children’s Hospital Boston document abnormalities in the brainstem — a part of the brain that regulates breathing, blood pressure, body heat, and arousal — in babies who died from SIDS. The term cot death is often used in the United Kingdom, and crib death in North America.

Sleep :: Lonely adults get stress hormone boost next morning

A new study that takes a rare look at the physiological, social and emotional dynamics of day-to-day experiences in real-life settings shows that when older adults go to bed lonely, sad or overwhelmed, they have elevated levels of cortisol shortly after waking the next morning.

Cholesterol :: Patent Victory in Spanish Court Favoring Ranbaxy on Atorvastatin Unaffected

Ranbaxy Laboratories Limited said that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer’s EP 409 281) to be invalid for lack of novelty. The two rulings made on September 26, 2006, in Lek Pharmaceuticals v. Warner Lambert Co. and in Laboratorios Cinfa et al. v. Warner Lambert, found claims 1 to 3 of Pfizer to be invalid. These decisions came after considering the views of the Spanish Patent Office (SPO), in addition to technical expert reports.

Flu :: Americans willing to make changes in their lives

In the case of an outbreak of pandemic flu, large majority of Americans willing to make major changes in their lives. Survey also finds many people would face critical work-related problems. The latest national survey conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that when faced with a serious outbreak of pandemic flu, a large majority of Americans are willing to make major changes in their lives and cooperate with public health officials’ recommendations.

Health :: Highest Honor awarded to infectious disease experts from Harvard School of Public Health

Harvard School of Public Health (HSPH) has awarded its highest honor, for the promotion of high public health standards among vulnerable populations, to William H. Foege, former Director of the U.S. Centers for Disease Control and a founder of the Task Force for Child Survival and Development, and Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID). The two recipients have dedicated their lives to protecting people in this country and throughout the world from infectious diseases.